Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cryosurgery | 29 | 2022 | 413 | 2.690 |
Why?
|
Magnetic Resonance Imaging, Interventional | 12 | 2018 | 192 | 1.590 |
Why?
|
Surgery, Computer-Assisted | 13 | 2020 | 1016 | 0.930 |
Why?
|
Liver Neoplasms | 24 | 2022 | 4102 | 0.860 |
Why?
|
Catheter Ablation | 22 | 2017 | 2558 | 0.850 |
Why?
|
Radiography, Interventional | 15 | 2017 | 1087 | 0.750 |
Why?
|
Biopsy, Needle | 14 | 2018 | 1673 | 0.700 |
Why?
|
Magnetic Resonance Imaging | 43 | 2021 | 34430 | 0.660 |
Why?
|
Prostate | 12 | 2021 | 1592 | 0.650 |
Why?
|
Kidney Neoplasms | 16 | 2020 | 4019 | 0.620 |
Why?
|
Cryotherapy | 7 | 2020 | 159 | 0.580 |
Why?
|
Prostatic Neoplasms | 19 | 2021 | 10605 | 0.540 |
Why?
|
Robotics | 6 | 2021 | 851 | 0.530 |
Why?
|
Tomography, X-Ray Computed | 37 | 2021 | 20357 | 0.460 |
Why?
|
Ablation Techniques | 4 | 2019 | 232 | 0.420 |
Why?
|
Fiducial Markers | 3 | 2020 | 137 | 0.400 |
Why?
|
Adrenal Gland Neoplasms | 4 | 2019 | 735 | 0.370 |
Why?
|
Radiology, Interventional | 8 | 2007 | 424 | 0.360 |
Why?
|
Needles | 6 | 2021 | 443 | 0.340 |
Why?
|
Subtraction Technique | 5 | 2016 | 544 | 0.300 |
Why?
|
Pseudomyxoma Peritonei | 1 | 2005 | 16 | 0.290 |
Why?
|
Carcinoma, Renal Cell | 6 | 2020 | 2956 | 0.270 |
Why?
|
Therapy, Computer-Assisted | 1 | 2007 | 276 | 0.270 |
Why?
|
Pattern Recognition, Automated | 5 | 2016 | 1019 | 0.260 |
Why?
|
Perineum | 6 | 2019 | 203 | 0.250 |
Why?
|
Aged, 80 and over | 41 | 2022 | 58326 | 0.220 |
Why?
|
Soft Tissue Neoplasms | 2 | 2008 | 1356 | 0.200 |
Why?
|
Fluorodeoxyglucose F18 | 4 | 2021 | 2025 | 0.200 |
Why?
|
Neoplasm Seeding | 2 | 2013 | 90 | 0.200 |
Why?
|
Digestive System Neoplasms | 2 | 2011 | 88 | 0.190 |
Why?
|
Drainage | 6 | 2004 | 1132 | 0.190 |
Why?
|
Motion | 3 | 2020 | 776 | 0.190 |
Why?
|
Aged | 60 | 2022 | 162468 | 0.190 |
Why?
|
Abdominal Neoplasms | 3 | 2008 | 300 | 0.190 |
Why?
|
Peritoneal Neoplasms | 1 | 2005 | 627 | 0.180 |
Why?
|
Image Interpretation, Computer-Assisted | 6 | 2019 | 3413 | 0.180 |
Why?
|
Portal Vein | 2 | 2016 | 425 | 0.180 |
Why?
|
Monitoring, Intraoperative | 2 | 2020 | 958 | 0.180 |
Why?
|
Image Enhancement | 5 | 2016 | 2979 | 0.180 |
Why?
|
Male | 80 | 2022 | 350352 | 0.170 |
Why?
|
Image Processing, Computer-Assisted | 6 | 2018 | 9004 | 0.170 |
Why?
|
Middle Aged | 59 | 2022 | 214666 | 0.160 |
Why?
|
Microwaves | 2 | 2017 | 177 | 0.160 |
Why?
|
Brachytherapy | 6 | 2014 | 1282 | 0.150 |
Why?
|
Intestines | 1 | 2006 | 1924 | 0.150 |
Why?
|
Humans | 101 | 2022 | 715818 | 0.150 |
Why?
|
Software | 5 | 2019 | 4396 | 0.150 |
Why?
|
Hepatic Veins | 1 | 2016 | 116 | 0.140 |
Why?
|
Retrospective Studies | 28 | 2022 | 72473 | 0.140 |
Why?
|
ACTH Syndrome, Ectopic | 1 | 2015 | 29 | 0.140 |
Why?
|
Treatment Outcome | 25 | 2022 | 62040 | 0.140 |
Why?
|
Catecholamines | 1 | 2015 | 391 | 0.130 |
Why?
|
Bone Neoplasms | 1 | 2007 | 2578 | 0.130 |
Why?
|
Biopsy | 7 | 2011 | 6737 | 0.130 |
Why?
|
Adrenalectomy | 1 | 2015 | 311 | 0.120 |
Why?
|
Sensitivity and Specificity | 14 | 2016 | 14902 | 0.120 |
Why?
|
Liver Diseases | 1 | 2002 | 1243 | 0.120 |
Why?
|
Models, Anatomic | 1 | 2017 | 687 | 0.120 |
Why?
|
Positron-Emission Tomography | 5 | 2021 | 6270 | 0.120 |
Why?
|
Neoplasm Recurrence, Local | 5 | 2016 | 8896 | 0.120 |
Why?
|
Gallbladder | 1 | 2014 | 297 | 0.120 |
Why?
|
Adrenal Glands | 1 | 2015 | 546 | 0.110 |
Why?
|
Pelvic Neoplasms | 2 | 2005 | 251 | 0.110 |
Why?
|
Female | 54 | 2022 | 377229 | 0.110 |
Why?
|
Adult | 40 | 2022 | 212279 | 0.110 |
Why?
|
Ethanol | 3 | 2008 | 1253 | 0.110 |
Why?
|
Radiation Dosage | 5 | 2015 | 2041 | 0.110 |
Why?
|
Stomach Diseases | 1 | 1992 | 130 | 0.100 |
Why?
|
Body Burden | 1 | 2011 | 164 | 0.100 |
Why?
|
Radiometry | 2 | 2011 | 812 | 0.100 |
Why?
|
Reproducibility of Results | 12 | 2018 | 19537 | 0.100 |
Why?
|
Urography | 2 | 2009 | 326 | 0.100 |
Why?
|
Feasibility Studies | 7 | 2011 | 4905 | 0.100 |
Why?
|
Ultrasonography | 6 | 2015 | 5922 | 0.090 |
Why?
|
Fluoroscopy | 4 | 2005 | 899 | 0.090 |
Why?
|
Imaging, Three-Dimensional | 4 | 2013 | 4029 | 0.090 |
Why?
|
Spinal Neoplasms | 1 | 2016 | 829 | 0.090 |
Why?
|
Forecasting | 1 | 2018 | 2956 | 0.080 |
Why?
|
Eosinophilia | 1 | 1992 | 510 | 0.080 |
Why?
|
Kidney | 3 | 2020 | 6882 | 0.080 |
Why?
|
Preoperative Care | 2 | 2010 | 2345 | 0.080 |
Why?
|
Artifacts | 1 | 2016 | 1912 | 0.080 |
Why?
|
Male Urogenital Diseases | 1 | 2008 | 50 | 0.080 |
Why?
|
Intestinal Diseases | 1 | 1992 | 511 | 0.080 |
Why?
|
Uncertainty | 1 | 2012 | 659 | 0.080 |
Why?
|
Ultrasonography, Interventional | 3 | 2006 | 1474 | 0.080 |
Why?
|
Female Urogenital Diseases | 1 | 2008 | 54 | 0.080 |
Why?
|
Myoglobin | 2 | 2011 | 158 | 0.080 |
Why?
|
Hepatectomy | 1 | 2010 | 563 | 0.080 |
Why?
|
Nephritis | 1 | 2007 | 158 | 0.080 |
Why?
|
Venous Thrombosis | 1 | 2016 | 1216 | 0.080 |
Why?
|
Postoperative Complications | 3 | 2016 | 15102 | 0.070 |
Why?
|
Algorithms | 7 | 2018 | 13758 | 0.070 |
Why?
|
Statistics, Nonparametric | 3 | 2015 | 2951 | 0.070 |
Why?
|
Furosemide | 1 | 2006 | 170 | 0.070 |
Why?
|
Kidney Tubules, Collecting | 1 | 2006 | 171 | 0.070 |
Why?
|
Pilot Projects | 5 | 2019 | 8075 | 0.070 |
Why?
|
Kidney Diseases | 2 | 2007 | 2124 | 0.070 |
Why?
|
Phantoms, Imaging | 5 | 2018 | 2418 | 0.070 |
Why?
|
Lung Neoplasms | 5 | 2014 | 12540 | 0.070 |
Why?
|
Gases | 1 | 2005 | 191 | 0.070 |
Why?
|
Intraoperative Period | 2 | 2018 | 535 | 0.060 |
Why?
|
Hematologic Diseases | 1 | 2008 | 490 | 0.060 |
Why?
|
Carcinoma, Hepatocellular | 2 | 2014 | 2091 | 0.060 |
Why?
|
Urology | 1 | 2009 | 369 | 0.060 |
Why?
|
Anesthesia, General | 2 | 2016 | 1103 | 0.060 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2016 | 2690 | 0.060 |
Why?
|
Sodium Chloride | 1 | 2006 | 630 | 0.060 |
Why?
|
Gastrointestinal Stromal Tumors | 2 | 2007 | 665 | 0.060 |
Why?
|
Brachial Plexus | 1 | 2005 | 169 | 0.060 |
Why?
|
Tumor Burden | 3 | 2015 | 1900 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2011 | 2757 | 0.060 |
Why?
|
Contrast Media | 3 | 2017 | 5276 | 0.060 |
Why?
|
Head and Neck Neoplasms | 1 | 2016 | 2719 | 0.060 |
Why?
|
Gadolinium DTPA | 2 | 2017 | 830 | 0.060 |
Why?
|
Bile | 1 | 2003 | 293 | 0.060 |
Why?
|
Liposarcoma | 1 | 2004 | 316 | 0.050 |
Why?
|
Nephrectomy | 1 | 2007 | 1005 | 0.050 |
Why?
|
Neoplasms | 4 | 2016 | 20528 | 0.050 |
Why?
|
Urethra | 1 | 2003 | 411 | 0.050 |
Why?
|
Models, Statistical | 1 | 2016 | 5065 | 0.050 |
Why?
|
Posture | 1 | 2005 | 986 | 0.050 |
Why?
|
Factor Analysis, Statistical | 1 | 2003 | 987 | 0.050 |
Why?
|
Telomerase | 1 | 2005 | 736 | 0.050 |
Why?
|
Pneumothorax | 1 | 2003 | 396 | 0.050 |
Why?
|
Rectum | 1 | 2003 | 883 | 0.040 |
Why?
|
Thermal Conductivity | 1 | 2017 | 15 | 0.040 |
Why?
|
Mathematical Concepts | 1 | 2017 | 57 | 0.040 |
Why?
|
Pancreatitis | 1 | 2004 | 1051 | 0.040 |
Why?
|
Pancreatic Neoplasms | 2 | 2006 | 4981 | 0.040 |
Why?
|
Adenocarcinoma | 3 | 2006 | 6324 | 0.040 |
Why?
|
Carcinoma, Papillary | 1 | 2002 | 793 | 0.040 |
Why?
|
Disease Progression | 3 | 2019 | 13215 | 0.040 |
Why?
|
Urinary Bladder | 1 | 2003 | 1136 | 0.040 |
Why?
|
Perfusion | 1 | 2021 | 1273 | 0.040 |
Why?
|
Predictive Value of Tests | 5 | 2015 | 15198 | 0.040 |
Why?
|
Liver | 2 | 2003 | 7594 | 0.040 |
Why?
|
Piperazines | 1 | 2007 | 2524 | 0.040 |
Why?
|
Societies, Medical | 1 | 2009 | 3754 | 0.040 |
Why?
|
Radio Waves | 1 | 2017 | 247 | 0.040 |
Why?
|
Gastrointestinal Hemorrhage | 1 | 2003 | 1073 | 0.040 |
Why?
|
Ureteroscopy | 1 | 1997 | 121 | 0.040 |
Why?
|
Pain | 2 | 2008 | 4697 | 0.040 |
Why?
|
Radiation Injuries | 1 | 2003 | 1224 | 0.040 |
Why?
|
Normal Distribution | 1 | 2016 | 283 | 0.040 |
Why?
|
Automation | 1 | 2018 | 589 | 0.030 |
Why?
|
Radiology | 1 | 2009 | 1949 | 0.030 |
Why?
|
Pyrimidines | 1 | 2007 | 2930 | 0.030 |
Why?
|
Swine | 2 | 2021 | 5802 | 0.030 |
Why?
|
Equipment Design | 2 | 2014 | 3587 | 0.030 |
Why?
|
Academic Medical Centers | 1 | 2005 | 2790 | 0.030 |
Why?
|
Ureter | 1 | 1997 | 363 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2009 | 3902 | 0.030 |
Why?
|
Cattle | 1 | 2020 | 3958 | 0.030 |
Why?
|
Temperature | 1 | 2020 | 2143 | 0.030 |
Why?
|
Palliative Care | 1 | 2008 | 3286 | 0.030 |
Why?
|
Boston | 3 | 2011 | 9377 | 0.030 |
Why?
|
Ultrasonic Therapy | 2 | 2007 | 234 | 0.030 |
Why?
|
Computer Simulation | 2 | 2018 | 6105 | 0.030 |
Why?
|
Abdomen | 1 | 1999 | 1101 | 0.030 |
Why?
|
Respiratory Mechanics | 1 | 2016 | 645 | 0.030 |
Why?
|
Linear Models | 1 | 2003 | 5984 | 0.030 |
Why?
|
Ileal Diseases | 1 | 1992 | 70 | 0.030 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2007 | 5198 | 0.030 |
Why?
|
Radiography | 3 | 2013 | 6980 | 0.030 |
Why?
|
Carcinoma | 1 | 2003 | 2320 | 0.030 |
Why?
|
Equipment Failure Analysis | 1 | 2014 | 863 | 0.030 |
Why?
|
Hyperplasia | 1 | 2015 | 1167 | 0.030 |
Why?
|
Lung | 2 | 2014 | 9739 | 0.030 |
Why?
|
Echo-Planar Imaging | 1 | 2016 | 675 | 0.030 |
Why?
|
Risk Assessment | 2 | 2015 | 23476 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 3525 | 0.030 |
Why?
|
Prospective Studies | 6 | 2014 | 51317 | 0.030 |
Why?
|
Survival Analysis | 2 | 2019 | 10503 | 0.030 |
Why?
|
Preoperative Period | 1 | 2013 | 554 | 0.030 |
Why?
|
Physicians | 1 | 2009 | 4375 | 0.030 |
Why?
|
Colonic Diseases | 1 | 1992 | 209 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2022 | 6730 | 0.020 |
Why?
|
Watchful Waiting | 1 | 2014 | 451 | 0.020 |
Why?
|
Occupational Exposure | 1 | 2000 | 1771 | 0.020 |
Why?
|
Calibration | 1 | 2012 | 797 | 0.020 |
Why?
|
Combined Modality Therapy | 3 | 2008 | 8890 | 0.020 |
Why?
|
Aspartate Aminotransferases | 1 | 2011 | 415 | 0.020 |
Why?
|
Hematocrit | 1 | 2011 | 637 | 0.020 |
Why?
|
Liver Function Tests | 1 | 2011 | 534 | 0.020 |
Why?
|
Relative Biological Effectiveness | 1 | 2011 | 341 | 0.020 |
Why?
|
Bilirubin | 1 | 2011 | 390 | 0.020 |
Why?
|
Ice | 1 | 2009 | 88 | 0.020 |
Why?
|
Clinical Protocols | 1 | 2015 | 1473 | 0.020 |
Why?
|
Intestinal Obstruction | 1 | 1992 | 421 | 0.020 |
Why?
|
Single-Blind Method | 1 | 2012 | 1581 | 0.020 |
Why?
|
Movement | 1 | 2016 | 1473 | 0.020 |
Why?
|
Prostatectomy | 1 | 2017 | 1796 | 0.020 |
Why?
|
Alanine Transaminase | 1 | 2011 | 602 | 0.020 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2016 | 1558 | 0.020 |
Why?
|
Platelet Count | 1 | 2011 | 795 | 0.020 |
Why?
|
Data Collection | 2 | 2009 | 3317 | 0.020 |
Why?
|
Alkaline Phosphatase | 1 | 2011 | 894 | 0.020 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2003 | 3994 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2012 | 986 | 0.020 |
Why?
|
Organ Size | 1 | 2012 | 2277 | 0.020 |
Why?
|
Safety | 1 | 2012 | 1217 | 0.020 |
Why?
|
Leukocyte Count | 1 | 2011 | 1660 | 0.020 |
Why?
|
Antineoplastic Agents | 2 | 2007 | 13626 | 0.020 |
Why?
|
Risk Factors | 4 | 2016 | 70879 | 0.020 |
Why?
|
Pancreas | 2 | 2004 | 1683 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4312 | 0.020 |
Why?
|
Data Interpretation, Statistical | 1 | 2016 | 2729 | 0.020 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2007 | 356 | 0.020 |
Why?
|
Time Factors | 3 | 2014 | 40887 | 0.020 |
Why?
|
Creatinine | 1 | 2011 | 1898 | 0.020 |
Why?
|
Bayes Theorem | 1 | 2012 | 2054 | 0.020 |
Why?
|
Chromans | 1 | 2004 | 125 | 0.020 |
Why?
|
Pancreatic Pseudocyst | 1 | 2004 | 109 | 0.020 |
Why?
|
Proportional Hazards Models | 1 | 2019 | 12460 | 0.020 |
Why?
|
Incidence | 2 | 2016 | 20733 | 0.020 |
Why?
|
History, 18th Century | 1 | 2004 | 217 | 0.020 |
Why?
|
Paralysis | 1 | 2005 | 241 | 0.020 |
Why?
|
Neural Conduction | 1 | 2005 | 478 | 0.020 |
Why?
|
Injections, Intralesional | 1 | 2004 | 281 | 0.020 |
Why?
|
Clone Cells | 1 | 2007 | 1760 | 0.020 |
Why?
|
Breast Neoplasms | 2 | 2009 | 20062 | 0.020 |
Why?
|
Reoperation | 1 | 2013 | 4177 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-kit | 1 | 2007 | 784 | 0.010 |
Why?
|
Follow-Up Studies | 4 | 2006 | 39305 | 0.010 |
Why?
|
Sequence Deletion | 1 | 2007 | 1550 | 0.010 |
Why?
|
Odds Ratio | 1 | 2015 | 9985 | 0.010 |
Why?
|
Survival Rate | 1 | 2017 | 13213 | 0.010 |
Why?
|
Thorax | 1 | 2005 | 515 | 0.010 |
Why?
|
Bile Ducts | 1 | 2003 | 290 | 0.010 |
Why?
|
Cholangiopancreatography, Endoscopic Retrograde | 1 | 2004 | 488 | 0.010 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2004 | 629 | 0.010 |
Why?
|
Benzamides | 1 | 2007 | 1390 | 0.010 |
Why?
|
Diagnosis, Differential | 2 | 2007 | 13219 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2015 | 12483 | 0.010 |
Why?
|
Radiology Department, Hospital | 1 | 2005 | 414 | 0.010 |
Why?
|
Thiazolidinediones | 1 | 2004 | 484 | 0.010 |
Why?
|
Diagnosis, Computer-Assisted | 1 | 2006 | 714 | 0.010 |
Why?
|
Electric Impedance | 1 | 2005 | 652 | 0.010 |
Why?
|
Intestinal Mucosa | 1 | 1992 | 3034 | 0.010 |
Why?
|
Thermoluminescent Dosimetry | 1 | 2000 | 27 | 0.010 |
Why?
|
Abscess | 1 | 2004 | 596 | 0.010 |
Why?
|
Animals | 3 | 2021 | 169404 | 0.010 |
Why?
|
Logistic Models | 1 | 2015 | 13623 | 0.010 |
Why?
|
Necrosis | 1 | 2004 | 1645 | 0.010 |
Why?
|
Peritoneum | 1 | 2000 | 229 | 0.010 |
Why?
|
Catheterization | 1 | 2004 | 1449 | 0.010 |
Why?
|
Models, Biological | 1 | 2016 | 9809 | 0.010 |
Why?
|
Prognosis | 1 | 2019 | 29007 | 0.010 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1938 | 0.010 |
Why?
|
Pain Measurement | 1 | 2008 | 3496 | 0.010 |
Why?
|
Models, Animal | 1 | 2005 | 2204 | 0.010 |
Why?
|
Muscular Diseases | 1 | 2002 | 549 | 0.010 |
Why?
|
Scattering, Radiation | 1 | 1999 | 522 | 0.010 |
Why?
|
Length of Stay | 1 | 2011 | 6270 | 0.010 |
Why?
|
Catheters, Indwelling | 1 | 1999 | 419 | 0.010 |
Why?
|
Laser Therapy | 1 | 2003 | 1070 | 0.010 |
Why?
|
Young Adult | 2 | 2016 | 56228 | 0.010 |
Why?
|
Prostatic Hyperplasia | 1 | 2000 | 506 | 0.010 |
Why?
|
Embolization, Therapeutic | 1 | 2005 | 1379 | 0.010 |
Why?
|
Vascular Surgical Procedures | 1 | 2003 | 1459 | 0.010 |
Why?
|
Adolescent | 2 | 2016 | 85157 | 0.010 |
Why?
|
Stomach Neoplasms | 1 | 2003 | 1245 | 0.010 |
Why?
|
Acute Disease | 1 | 2004 | 7142 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2011 | 21795 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2003 | 2556 | 0.010 |
Why?
|
Neoplasm Staging | 1 | 2006 | 11145 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2005 | 11945 | 0.010 |
Why?
|
Practice Guidelines as Topic | 1 | 2007 | 7446 | 0.010 |
Why?
|
United States | 2 | 2009 | 67910 | 0.010 |
Why?
|
Patient Selection | 1 | 2000 | 4294 | 0.010 |
Why?
|